43602-419-10 |
43602-419 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.075 mg/1 |
1000 TABLET in 1 BOTTLE (43602-419-10) |
43602-419-30 |
43602-419 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.075 mg/1 |
30 TABLET in 1 BOTTLE (43602-419-30) |
43602-419-90 |
43602-419 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.075 mg/1 |
90 TABLET in 1 BOTTLE (43602-419-90) |
43602-423-10 |
43602-423 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.125 mg/1 |
1000 TABLET in 1 BOTTLE (43602-423-10) |
43602-423-30 |
43602-423 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.125 mg/1 |
30 TABLET in 1 BOTTLE (43602-423-30) |
43602-423-90 |
43602-423 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.125 mg/1 |
90 TABLET in 1 BOTTLE (43602-423-90) |
43602-427-10 |
43602-427 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.2 mg/1 |
1000 TABLET in 1 BOTTLE (43602-427-10) |
43602-427-30 |
43602-427 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.2 mg/1 |
30 TABLET in 1 BOTTLE (43602-427-30) |
43602-427-90 |
43602-427 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.2 mg/1 |
90 TABLET in 1 BOTTLE (43602-427-90) |
31722-286-01 |
31722-286 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.075 mg/1 |
100 TABLET in 1 BOTTLE (31722-286-01) |
31722-286-10 |
31722-286 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Camber Pharmaceuticals, Inc. |
LEVOTHYROXINE SODIUM |
.075 mg/1 |
1000 TABLET in 1 BOTTLE (31722-286-10) |
43602-420-10 |
43602-420 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.088 mg/1 |
1000 TABLET in 1 BOTTLE (43602-420-10) |
43602-420-30 |
43602-420 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.088 mg/1 |
30 TABLET in 1 BOTTLE (43602-420-30) |
43602-420-90 |
43602-420 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.088 mg/1 |
90 TABLET in 1 BOTTLE (43602-420-90) |
43602-424-10 |
43602-424 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.137 mg/1 |
1000 TABLET in 1 BOTTLE (43602-424-10) |
43602-424-30 |
43602-424 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.137 mg/1 |
30 TABLET in 1 BOTTLE (43602-424-30) |
43602-424-90 |
43602-424 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.137 mg/1 |
90 TABLET in 1 BOTTLE (43602-424-90) |
43602-428-10 |
43602-428 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.3 mg/1 |
1000 TABLET in 1 BOTTLE (43602-428-10) |
43602-428-30 |
43602-428 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.3 mg/1 |
30 TABLET in 1 BOTTLE (43602-428-30) |
43602-428-90 |
43602-428 |
HUMAN PRESCRIPTION DRUG |
LEVOTHYROXINE SODIUM |
levothyroxine sodium |
TABLET |
ORAL |
20230118 |
N/A |
ANDA |
ANDA215259 |
Ascent Pharmaceuticals, Inc |
LEVOTHYROXINE SODIUM |
.3 mg/1 |
90 TABLET in 1 BOTTLE (43602-428-90) |